Omeprazole Market Size

  • Report ID: 2477
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Omeprazole Market Outlook:

Omeprazole Market size was valued at USD 1.25 billion in 2025 and is likely to cross USD 2.35 billion by 2035, expanding at more than 6.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of omeprazole is assessed at USD 1.32 billion.

Increasing cases of chronic diseases globally are boosting market growth. As per a report generated by WHO, at the end of 2050 chronic diseases such as cancer, diabetes, and respiratory ailments will be responsible for a startling 90% of all global fatalities.

Positive results during the clinical trials of omeprazole in H. pylori elimination therapy are anticipated to increase the demand for omeprazole globally during the foreseen period. In order to treat Helicobacter pylori infection, RedHill Biopharma, for example, recently published the phase 3 findings of the Talicia capsule, which combines antibiotics and a proton pump inhibitor.


Omeprazole Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of omeprazole is assessed at USD 1.32 billion.

The global omeprazole market size was around USD 1.25 billion in 2025 and is likely to expand at a CAGR of more than 6.5%, surpassing USD 2.35 billion revenue by 2035.

By 2035, North America is projected to command a 59% revenue share in the omeprazole market because of rising ulcer prevalence and supportive cost-saving prescription services.

Key players in the market include Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc., Salix pharmaceuticals.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos